View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Diabetes News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 09, 2024
2 min read
Save

Noninvasive radiofrequency sensor with machine learning may accurately measure glucose

Noninvasive radiofrequency sensor with machine learning may accurately measure glucose

NEW ORLEANS —A noninvasive device using a radiofrequency sensor may be able to measure glucose levels for people with diabetes in the future, according to a speaker at the AACE Annual Meeting.

SPONSORED CONTENT
May 09, 2024
4 min read
Save

Referral program boosts postpartum visits to primary care during year after delivery

Referral program boosts postpartum visits to primary care during year after delivery

Women with gestational diabetes or hypertension referred from obstetrics to a primary care provider after delivery were six times more likely to attend a visit with a PCP in the first year postpartum, data show.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
May 09, 2024
4 min read
Save

AI, new technology major focus at 2024 AACE annual meeting

AI, new technology major focus at 2024 AACE annual meeting

Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.

SPONSORED CONTENT
May 07, 2024
1 min watch
Save

VIDEO: Cardiovascular benefits of GLP-1 agonists ‘absolutely stunning’

VIDEO: Cardiovascular benefits of GLP-1 agonists ‘absolutely stunning’

BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

SPONSORED CONTENT
May 07, 2024
4 min read
Save

Important updates in cardiology from Clyde W. Yancy, MD, MSc

Important updates in cardiology from Clyde W. Yancy, MD, MSc

BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.

SPONSORED CONTENT
May 07, 2024
2 min read
Save

GLP-1 receptor agonist use not linked to respiratory complication risk after surgery

GLP-1 receptor agonist use not linked to respiratory complication risk after surgery

Among patients with diabetes undergoing emergency surgery, the risk for respiratory complications afterward was not heightened with glucagon-like peptide-1 receptor agonist use, according to a research letter published in JAMA.

SPONSORED CONTENT
May 03, 2024
2 min read
Save

GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors

GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors

Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.

SPONSORED CONTENT
May 01, 2024
2 min read
Save

Combined insomnia, OSA phenotype predicts incident diabetes in men

Combined insomnia, OSA phenotype predicts incident diabetes in men

In older men, the sleep breathing impairment index definition of combined insomnia-obstructive sleep apnea predicted incident diabetes, according to results published in Annals of the American Thoracic Society.

SPONSORED CONTENT
April 30, 2024
1 min read
Save

Fully-implantable CGM receives FDA authorization for integration with insulin pumps

Fully-implantable CGM receives FDA authorization for integration with insulin pumps

The FDA granted integrated continuous glucose monitoring designation to a fully-implantable CGM, according to a press release.

SPONSORED CONTENT
April 29, 2024
2 min read
Save

Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome

Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome

More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails